209 related articles for article (PubMed ID: 17675904)
1. Introduction: organ involvement in the cardiometabolic syndrome.
Hayden MR; Stump CS; Sowers JR
J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic steatohepatitis and the cardiometabolic syndrome.
Abdeen MB; Chowdhury NA; Hayden MR; Ibdah JA
J Cardiometab Syndr; 2006; 1(1):36-40. PubMed ID: 17675901
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic syndrome and chronic kidney disease: what is the link?
Sarafidis PA; Whaley-Connell A; Sowers JR; Bakris GL
J Cardiometab Syndr; 2006; 1(1):58-65. PubMed ID: 17675896
[TBL] [Abstract][Full Text] [Related]
4. Eicosanoids and renal damage in cardiometabolic syndrome.
Imig JD
Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):165-74. PubMed ID: 18248310
[TBL] [Abstract][Full Text] [Related]
5. The cardiometabolic syndrome and liver disease.
Sowers JR
J Cardiometab Syndr; 2008; 3(1):5-6. PubMed ID: 18326973
[No Abstract] [Full Text] [Related]
6. Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
Hayden MR; Chowdhury N; Govindarajan G; Karuparthi PR; Habibi J; Sowers JR
J Cardiometab Syndr; 2006; 1(5):326-33. PubMed ID: 17679785
[TBL] [Abstract][Full Text] [Related]
7. Nitrosative Stress and Its Association with Cardiometabolic Disorders.
Pérez-Torres I; Manzano-Pech L; Rubio-Ruíz ME; Soto ME; Guarner-Lans V
Molecules; 2020 May; 25(11):. PubMed ID: 32486343
[No Abstract] [Full Text] [Related]
8. [Fatty liver and global cardiometabolic risk].
Szollár L
Orv Hetil; 2010 Nov; 151(47):1946-50. PubMed ID: 21071306
[TBL] [Abstract][Full Text] [Related]
9. [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome].
Carvalheira JB; Saad MJ
Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):360-7. PubMed ID: 16767302
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Syndrome: One Speckled Stone Kills a Flock of Birds?
Bonde Y; Angelin B
Trends Mol Med; 2017 Feb; 23(2):97-99. PubMed ID: 28082126
[TBL] [Abstract][Full Text] [Related]
11. The cardiometabolic syndrome as a cardiovascular risk factor.
Govindarajan G; Whaley-Connell A; Mugo M; Stump C; Sowers JR
Am J Med Sci; 2005 Dec; 330(6):311-8. PubMed ID: 16355016
[TBL] [Abstract][Full Text] [Related]
12. Chronic kidney disease and the cardiometabolic syndrome.
Whaley-Connell A; Sowers JR
J Clin Hypertens (Greenwich); 2006 Aug; 8(8):546-8. PubMed ID: 16896269
[No Abstract] [Full Text] [Related]
13. Metabolic syndrome and non-alcoholic fatty liver disease.
Almeda-Valdés P; Cuevas-Ramos D; Aguilar-Salinas CA
Ann Hepatol; 2009; 8 Suppl 1():S18-24. PubMed ID: 19381120
[TBL] [Abstract][Full Text] [Related]
14. The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.
Mikhailidis DP; Press M
Expert Opin Pharmacother; 2007 Dec; 8(17):3009-20. PubMed ID: 18001259
[TBL] [Abstract][Full Text] [Related]
15. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
Ferdinand KC
J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
[TBL] [Abstract][Full Text] [Related]
16. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte.
Hayden MR; Whaley-Connell A; Sowers JR
Am J Nephrol; 2005; 25(6):553-69. PubMed ID: 16210838
[TBL] [Abstract][Full Text] [Related]
17. Obstructive sleep apnoea and cardiovascular complications: perception versus knowledge.
Thomas JJ; Ren J
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):995-1003. PubMed ID: 23082844
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and vascular risk.
Bhatia LS; Curzen NP; Byrne CD
Curr Opin Cardiol; 2012 Jul; 27(4):420-8. PubMed ID: 22596186
[TBL] [Abstract][Full Text] [Related]
19. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
20. The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.
Nakao H; Yoneda M
J Gastroenterol; 2009; 44(11):1162-4. PubMed ID: 19802516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
